Texas 2017 - 85th Regular

Texas Senate Bill SB1774

Caption

Relating to the use of certain controlled substances by women who are pregnant or may become pregnant and the designation of neonatal abstinence syndrome from substance use as a reportable condition.

Impact

The bill's implementation will have significant implications for healthcare practices involving expectant mothers. Specifically, it establishes a system for screening and potentially reporting cases of neonatal abstinence syndrome, a condition affecting newborns whose mothers used addictive drugs during pregnancy. By making this condition reportable, it aims to enhance public health tracking and response strategies. Additionally, physicians will be required to access patients' prescription histories to better understand and manage potential risks related to opioid exposure for both mothers and newborns.

Summary

SB1774 aims to regulate the use of certain controlled substances by women who are pregnant or may become pregnant. The bill introduces mandatory initial substance use screening during the first healthcare visit for pregnant women using a validated screening tool. This measure is designed to identify potential substance use issues early and facilitate timely intervention. Moreover, the bill includes provisions to inform women about the risks of opioid use during pregnancy and requires physicians to document their compliance with these new screening protocols.

Contention

Some notable points of contention surrounding SB1774 include concerns about privacy and the responsibility placed on healthcare providers. Critics might argue that requiring health providers to report substance use can infringe on patient confidentiality, particularly concerning vulnerable populations such as pregnant women. Supporters of the bill, though, argue that the potential benefits of reducing neonatal abstinence syndrome and improving maternal health outcomes justify these measures. The balance between maternal rights and public health priorities is likely to be a key area of debate as the bill progresses.

Companion Bills

No companion bills found.

Previously Filed As

TX SB673

Relating to the reporting and investigating certain causes of child abuse or neglect involving a pregnant woman's use of a controlled substance.

TX HB811

Relating to reporting and investigating certain cases of child abuse or neglect involving a pregnant person's use of a controlled substance.

TX HB1958

Relating to maternal mortality and morbidity in this state and Medicaid eligibility of and coverage for certain services provided to pregnant women.

TX HB4642

Relating to offenses involving the manufacture or delivery of certain controlled substances and the enforcement and prevention of those offenses; creating a criminal offense.

TX HB1575

Relating to improving health outcomes for pregnant women under Medicaid and certain other public benefits programs.

TX HB56

Relating to the Medicaid eligibility of certain women following a pregnancy.

TX HB3058

Relating to the provision of certain medical treatment to a pregnant woman by a physician or health care provider.

TX HB1190

Relating to the prescribing and ordering of Schedule II controlled substances by certain advanced practice registered nurses and physician assistants.

TX HB5298

Relating to a pilot program under which lockable, tamper-evident containers are used by participating pharmacies when dispensing schedule II controlled substances.

TX SB124

Relating to the Medicaid eligibility of certain women during and following a pregnancy.

Similar Bills

NJ A520

Establishes public awareness campaign about Pregnant Women/Women With Dependent Children initiative and Maternal Wrap Around program.

KY HB368

AN ACT relating to maternal health.

TX SB26

Relating to the use of certain controlled substances by women who are pregnant or may become pregnant and the designation of neonatal abstinence syndrome from substance use as a reportable condition.

TX HB109

Relating to the use of certain controlled substances by women who are pregnant or may become pregnant and the designation of neonatal abstinence syndrome from substance use as a reportable condition.

LA SB174

Provides relative to certain pregnancy screenings. (gov sig) (EN INCREASE GF EX See Note)

MN SF2543

Terminology modification for pregnant persons

MN HF2095

Terminology for pregnant persons modified, standards for chemical dependency in pregnancy and prenatal substance use modified, prenatal substance use specified to not itself constitute neglect or maltreatment, reporting requirements modified, and informed consent requirements established for parent and newborn infant toxicology tests and drug or alcohol screenings.

ND SB2232

Reporting requirements for prenatal exposure to alcohol misuse.